ImCheck Therapeutics Funding: $154M Raised, Series B (2020)
ImCheck Therapeutics is based in Marseille, France. It has raised $154M in total funding. Latest round: Series B.
ImCheck Therapeutics funding overview
ImCheck Therapeutics is based in Marseille, France. ImCheck Therapeutics has raised $154M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in September 2020. The round record for ImCheck Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Bpifrance, Pfizer Ventures, Earlybird, Andera Partners, Kurma Partners, Eurazeo and 7 others. 13 distinct backers are named across the disclosed rounds.
Frequently asked about ImCheck Therapeutics funding
How much has ImCheck Therapeutics raised?
ImCheck Therapeutics has raised $154M in total disclosed funding across the rounds on record.
Who has invested in ImCheck Therapeutics?
Bpifrance, Pfizer Ventures, Earlybird, Andera Partners, Kurma Partners, Eurazeo are named among the investors backing ImCheck Therapeutics.
What was the latest ImCheck Therapeutics funding round?
The most recent disclosed round is a Series B, announced in September 2020.
Where is ImCheck Therapeutics based?
ImCheck Therapeutics is based in Marseille, France.
When did ImCheck Therapeutics last raise?
The last disclosed ImCheck Therapeutics round closed in September 2020 at Series B.
Every ImCheck Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Marseille at a similar stage.
